Home » Roche Taps Psynova to Develop Schizophrenia Companion Diagnostic
Roche Taps Psynova to Develop Schizophrenia Companion Diagnostic
Roche is exploiting U.K.-based Psynova Neurotech’s expertise for
the development of immunoassay-based companion diagnostics for its schizophrenia candidates.
GEN
GEN
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May